222 related articles for article (PubMed ID: 37938504)
21. Clinico-pathological spectrum of primary ovarian malignant mixed mullerian tumors (OMMMT) from a tertiary cancer institute: A series of 27 cases.
Menon S; Deodhar K; Rekhi B; Dhake R; Gupta S; Ghosh J; Maheshwari A; Mahantshetty U; Shrivastva S; Budukh A; Tongaonkar HB; Kerkar R
Indian J Pathol Microbiol; 2013; 56(4):365-71. PubMed ID: 24441223
[TBL] [Abstract][Full Text] [Related]
22. Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.
Tymon-Rosario JR; Manara P; Manavella DD; Bellone S; Hartwich TMP; Harold J; Yang-Hartwich Y; Zipponi M; Choi J; Jeong K; Mutlu L; Yang K; Altwerger G; Menderes G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Alexandrov LB; Santin AD
Gynecol Oncol; 2022 Jul; 166(1):117-125. PubMed ID: 35599167
[TBL] [Abstract][Full Text] [Related]
23. Genetic Analysis and Combined Therapy of Surgery and Chemotherapy for the Progression-Free Survival of a Patient with Ovarian Carcinosarcoma: A Case Report and Literature Review.
Guo S; Zhang X; Tang Q; Zhou M; Jiang D; Yu E
Onco Targets Ther; 2022; 15():717-725. PubMed ID: 35791423
[TBL] [Abstract][Full Text] [Related]
24. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis.
Rauh-Hain JA; Gonzalez R; Bregar AJ; Clemmer J; Hernández-Blanquisett A; Clark RM; Schorge JO; Del Carmen MG
Gynecol Oncol; 2016 Jul; 142(1):38-43. PubMed ID: 27107722
[TBL] [Abstract][Full Text] [Related]
25. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
[TBL] [Abstract][Full Text] [Related]
26. Primary ovarian carcinosarcoma: a case report and review of the literature.
Varras M; Akrivis Ch; Antoniou N; Tolis C; Stefanaki S; Salamalekis E
Eur J Gynaecol Oncol; 2004; 25(5):653-6. PubMed ID: 15493190
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma.
Zhu J; Wen H; Ju X; Bi R; Zuo W; Wu X
PLoS One; 2017; 12(1):e0170879. PubMed ID: 28125702
[TBL] [Abstract][Full Text] [Related]
28. Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.
Coosemans A; Vanderstraeten A; Tuyaerts S; Verschuere T; Moerman P; Berneman Z; Vergote I; Amant F; Van Gool SW
Anticancer Res; 2013 Sep; 33(9):3855-9. PubMed ID: 24023319
[TBL] [Abstract][Full Text] [Related]
29. Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Elattar A; Bryant A; Winter-Roach BA; Hatem M; Naik R
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD007565. PubMed ID: 21833960
[TBL] [Abstract][Full Text] [Related]
30. Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients.
Chang J; Sharpe JC; A'Hern RP; Fisher C; Blake P; Shepherd J; Gore ME
Ann Oncol; 1995 Oct; 6(8):755-8. PubMed ID: 8589011
[TBL] [Abstract][Full Text] [Related]
31. Ovarian Carcinosarcoma and Response to Immunotherapy.
Daniyal M; Polani AS; Canary M
Cureus; 2023 Apr; 15(4):e37149. PubMed ID: 37153309
[TBL] [Abstract][Full Text] [Related]
32. Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma.
Hollis RL; Croy I; Churchman M; Bartos C; Rye T; Gourley C; Herrington CS
Br J Cancer; 2022 Oct; 127(6):1034-1042. PubMed ID: 35715633
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases.
Ariyoshi K; Kawauchi S; Kaku T; Nakano H; Tsuneyoshi M
Histopathology; 2000 Nov; 37(5):427-36. PubMed ID: 11119124
[TBL] [Abstract][Full Text] [Related]
34. Primary Ovarian Malignant Mixed Mullerian Tumour: A Case Report and Brief Review of Literature.
Uçar MG; Çakir T; Ilhan TT; Karabagli P; Çelik Ç
J Clin Diagn Res; 2016 Mar; 10(3):QD04-6. PubMed ID: 27134951
[TBL] [Abstract][Full Text] [Related]
35. Uterine and Ovarian Carcinosarcomas: Do They Behave Similarly?
Ureyen I; Karalok A; Cirik DA; Tasci T; Gokce ZK; Duzguner IB; Tulunay G; Turan T
J Obstet Gynaecol Can; 2017 Jul; 39(7):559-563. PubMed ID: 28625283
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features of ovarian carcinosarcomas: a single institution experience.
Zorzou MP; Markaki S; Rodolakis A; Kastritis E; Bozas G; Dimopoulos MA; Papadimitriou CA
Gynecol Oncol; 2005 Jan; 96(1):136-42. PubMed ID: 15589592
[TBL] [Abstract][Full Text] [Related]
37. Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
Matsuura Y; Kitajima M; Hachisuga T; Tanimoto A; Okura N; Kihara I
J Obstet Gynaecol Res; 2010 Aug; 36(4):907-11. PubMed ID: 20666968
[TBL] [Abstract][Full Text] [Related]
38. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Ho GY; Kyran EL; Bedo J; Wakefield MJ; Ennis DP; Mirza HB; Vandenberg CJ; Lieschke E; Farrell A; Hadla A; Lim R; Dall G; Vince JE; Chua NK; Kondrashova O; Upstill-Goddard R; Bailey UM; Dowson S; Roxburgh P; Glasspool RM; Bryson G; Biankin AV; ; Cooke SL; Ratnayake G; McNally O; Traficante N; ; DeFazio A; Weroha SJ; Bowtell DD; McNeish IA; Papenfuss AT; Scott CL; Barker HE
Cancer Res; 2022 Dec; 82(23):4457-4473. PubMed ID: 36206301
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Niraparib as Maintenance Therapy in A Patient With Ovarian Carcinosarcoma.
Zhang JQ; Zhao BB; Wang MM; Li L
Front Oncol; 2021; 11():603591. PubMed ID: 34938651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
